✦ LIBER ✦

PCV34 COST-EFFECTIVENESS OF ANTICOAGULATION WITH BIVALIRUDIN VS. HEPARIN AND GLYCOPROTEIN INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION IN SWEDEN

✍ Scribed by S Borg; U Persson; TB Conradson; K Ericsson

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV38 COST MINIMIZATION ANALYSIS OF BIVA

✍ Á Cequier; C Morís; X Badia; N Lara 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Safety and Efficacy of Prasugrel Use in

✍ Laynez, Ana; Sardi, Gabriel; Torguson, Rebecca; Xue, Zhenyi; Suddath, William O. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 118 KB

PCV85 PRASUGREL VS. CLOPIDOGREL IN PATIE

✍ A Davies; MJ Sculpher; A Barrett; A Valladares; T Huete; T Dilla 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Angiographic and clinical outcomes of bi

✍ Fadi Matar; Colleen Donoghue; Peter Rossi; Michel Vandormael; John T. Sullebarge 📂 Article 📅 2006 🏛 Pulsus Group Inc 🌐 English ⚖ 185 KB

TCT-169: Safety and Efficacy for the Use

📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 239 KB

Cost analysis of bivalirudin versus refe

✍ Puymirat, E.; Cohen, S.; Védrenne, G.; Caruba, T.; Sabatier, B.; Danchin, N.; Du 📂 Article 📅 2013 🏛 Elsevier Science 🌐 French ⚖ 287 KB